98%
921
2 minutes
20
Background: A key outcome in aesthetic treatments is the patient's view of how their skin looks and feels after a treatment.
Objectives: The aim of this study was to add a Treatment Outcome scale to the SKIN-Q patient-reported outcome measure.
Methods: Concept elicitation interviews were performed with patients in Canada and the United States. Data were coded, analyzed, and used to draft a Treatment Outcome scale. The scale was refined with patient and expert feedback and field tested in an online sample (ie, Prolific). Psychometric analyses were performed to examine reliability and validity.
Results: The concept elicitation interviews included 26 participants. The first draft of the Treatment Outcome scale included 32 items that assessed changes in appearance (eg, look better) and well-being (eg, feel more confident). Items were revised with input from 12 experts, 11 patients, and 174 online participants who had aesthetic face and/or body treatments and provided 180 survey responses, resulting in 36 items. Prolific data from 499 participants provided 542 assessments. The sample comprised 80.6% women; 78.8% had a facial treatment, 11.4% had a body treatment, and 9.8% had both. Data for a final 10-item Treatment Outcome scale fit the Rasch model (chi-square = 50.46, df = 40, P = .124). The scale evidenced high reliability, with the person separation index, Cronbach α, and intraclass correlation coefficent values ≥.87. A total of 19 out of 22 (86%) predefined construct validation hypotheses were accepted.
Conclusions: This new SKIN-Q scale can be used alongside other patient-centered outcome tools to measure outcomes of minimally invasive aesthetic treatments.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12358213 | PMC |
http://dx.doi.org/10.1093/asj/sjaf075 | DOI Listing |
Clin Transl Oncol
September 2025
Spanish Society of Medical Oncology (SEOM) Thrombosis and Cancer Group, Madrid, Spain.
Purpose: To determine the real-world incidence and predictive factors for venous and arterial thromboembolic events (VTE/AT) in ovarian cancer patients treated with poly-(ADP-ribose) polymerase inhibitors (iPARP).
Methods/patients: A multicenter retrospective study involving 329 ovarian cancer patients who initiated iPARP treatment between January 2015 and December 2022. The primary outcome was the incidence of VTE/AT.
J Robot Surg
September 2025
Department of Urology, Rennes University Hospital, Rennes, France.
The surgical approach of ureteral stricture has changed dramatically over the past 15 years with the rise of robotic upper urinary tract reconstruction. This study aimed to evaluate the outcomes of all robotic ureteral reconstructions performed at a single academic center for ureteral stricture and to assess the predictive factors of stricture recurrence. The charts of all patients who underwent robot-assisted ureteral reconstruction between 2013 and 2024 at a single academic center were retrospectively reviewed.
View Article and Find Full Text PDFPituitary
September 2025
Facoltà Di Medicina E Chirurgia, Università Cattolica del Sacro Cuore, Rome, Italy.
Introduction: Pituitary adenomas (PAs) are generally benign neoplasms, though in rare cases may exhibit aggressive behavior. In 2024, the PANOMEN-3 workshop released a new clinical-pathological classification. The objective of this study was to examine the potential of the PANOMEN-3 classification to predict prognosis of PAs and guide treatment in our single center cohort of patients with PAs.
View Article and Find Full Text PDFHand (N Y)
September 2025
Department of Hand and Orthopedic Surgery, Faculty of Medicine and Health, Örebro University, Sweden.
Background: In distal radius fracture (DRF) surgery with volar locking plates, the flexor carpi radialis approach is commonly used. However, the volar central approach (VCA), between the median nerve and the finger flexors, may improve visualization of the volar ulnar corner. A similar approach has been linked with a higher risk of iatrogenic median neuropathy.
View Article and Find Full Text PDFAnn Surg Oncol
September 2025
Department of Surgery, Komfo Anoyke Teaching Hospital, Kumasi, Ghana.
The International Center for the Study of Breast Cancer Subtypes (ICSBCS) has played a vital role in defining and overcoming many inequities that exist in breast cancer treatment and outcome on a global basis through capacity-building programs that improve the management of breast cancer patients across the African diaspora. ICSBCS activities also fill critical gaps in disparities research related to the genetics of ancestry. Over the past 20 years, ICSBCS teams have spearheaded landmark studies documenting the relevance of genetic African ancestry to breast cancer risk, while also improving the quality of care delivered to patients in diverse communities.
View Article and Find Full Text PDF